Netherlands vs Sweden: Share of E. coli infections resistant to cephalosporins
Netherlands
7.6%
in 2022
Sweden
7.3%
in 2022
Netherlands rank
43rd
Sweden rank
44th
Share of E. coli infections resistant to cephalosporins over time
- Netherlands
- Sweden
How they compare
Netherlands currently reports 7.6% against 7.3% in Sweden, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Sweden ahead.
Netherlands ranks 43rd and Sweden ranks 44th of 46 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.9% | 7.8% | 0.9% | Sweden |
| 2020s | 7.0% | 7.3% | 0.4% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Netherlands or Sweden?
- Netherlands, at 7.6% against 7.3% in Sweden as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Netherlands and Sweden?
- 0.3%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Sweden?
- 6 years are reported by both, from 2017 to 2022.
- How do Netherlands and Sweden rank globally for share of e. coli infections resistant to cephalosporins?
- Netherlands ranks 43rd and Sweden ranks 44th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).